Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis

Hepatology

Volumn 45, Issue 4, 2007, Pages 977-981

  Robertson, Helen ^a   Kirby, John A ^a   Yip, William W ^a   Jones, David E J ^a   Burt, Alastair D ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALVASCULIN; COLESTYRAMINE; NALTREXONE; RIFAMPICIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; URSODEOXYCHOLIC ACID; VIMENTIN;

ADULT; ARTICLE; CASE REPORT; CELL TRANSFORMATION; CLINICAL FEATURE; EPITHELIUM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LIVER BIOPSY; LIVER TRANSPLANTATION; MESENCHYME; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; TISSUE DIFFERENTIATION;

ADULT; BIOLOGICAL MARKERS; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; RECURRENCE;

EID: 34247334927     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21624     Document Type: Article

References (21)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. New Eng J Med 2005;353:1261-1273.
2. Jones DEJ. Pathogenesis of primary biliary cirrhosis. J Hepatol 2003;39: 639-648.
3. Harada K, Nakanuma Y. Molecular mechanisms of cholangiopathy in primary biliary cirrhosis. Med Mol Morphol 2006;38:55-61.
4. Alvaro D, Floreani A, Onori R, Franchitto A, Mancino MG, Guido M, et al. The activation of IGF1 system is a requisite for cholangiocyte survival during the progression of primary biliary cirrhosis (PBC). J Hepatol 2006; 44:S121-S122.
5. Garcia RFL, Garcia CE, McMaster P, Neuberger J. Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single center. HEPATOLOGY 2001;33:22-27.
6. Guy JE, Qian PQ, Lowell JA, Peters MG. Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant. Liver Transpl 2005;11:1252-1257.
7. Van de Water J, Gerson LB, Ferrell LD, Lake JR, Coppel RL, Batts KP, et al. Immuno-histochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. HEPATOLOGY 1996;24:1079-1084.
8. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition:new insights in signaling, development and disease. J Cell Biol 2006;172:973-981.
9. Robertson H, Ali S, McDonnell BJ, Burt AD, Kirby JA. Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition. J Am Soc Nephrol 2004;15:390-397.
10. Tyler JR, Robertson H, Booth TA, Burt AD, Kirby JA. Chronic allograft nephropathy: intraepithelial signals generated by transforming growth factor-beta and bone morphogenetic protein-7. Am J Transplant 2006;6: 1367-1376.
11. Rygiel KA, Robertson H, Burt AD, Jones DEJ, Kirby JA. Demonstration of the transition of intrahepatic biliary epithelial cells to fibroblasts during chronic inflammatory liver diseases. J Hepatol 2006;45:S241 (abstract).
12. Vongwiwatana A, Tasanarong A, Rayner DC, Melk A, Halloran PF. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. Am J Transplant 2005;5:1367-1374.
13. Robertson H, Xu X, Burt AD, Kirby JA. Epithelial to mesenchymal transition in chronic cholestatic liver disease. J Pathol 2005;207:30A (abstract).
14. Mishra B, Tang Y, Katuri V, Fleury T, Said AH, Rashid A, et al. Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis. Liver Int 2004;24:637-645.
15. Xia J-L, Dai C, Michalopoulos GK, Liu Y. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol 2006; 168:1500-1512.
16. del Castillo G, Murillo MM, Alvarez-Barrientos A, Bertran E, Fernandez M, Sanchez A, et al. Autocrine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: Role of EGF receptor ligands. Exp Cell Res 2006; 312:2860-2871.
17. Rodrigues CMP, Fan GS, Ma XM, Kren BT, Steer CJ. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998;101:2790-2799.
18. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, et al. BMP-7 counteracts TGF-B1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003;9:964-967.
19. Wu M-J, Wen M-C, Chiu Y-Y, Shu K-H, Tang M-J. Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int 2006;69:2029-2036.
20. Biecker E, Gottardi AD, Neef M, Unternahrer M, Schneider V, Ledermann M, et al. Long-term tteatment of bile-duct-ligated rats bwith rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms. J Pharmacol ExpTher 2005;313:952-961.
21. Slattery C, McMorrow T, Ryan MP. Overexpression of E2A proteins induces epithelial-mesenchymal transition in human renal proximal tubular epithelial cells suggesting a potential role in renal fibrosis. FEBS Lett 2006;580:4021-4030.